- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01828216
Ambulatory Versus Conventional Approach Diagnosing OSA
February 26, 2016 updated by: Prof David Shu Cheong Hui, Chinese University of Hong Kong
A Randomized Controlled Study Assessing the Role of an Ambulatory Approach Versus the Conventional Approach in Managing Suspected Obstructive Sleep Apnoea Syndrome
Very few studies have examined different models of care involving initial ambulatory home-based diagnosis in diagnosing obstructive sleep apnea (OSA), identifying patients who benefit from continuous positive airway pressure (CPAP), and reducing the need for polysomnography (PSG).
This study aims to assess the role of an ambulatory approach with home diagnostic sleep study.
We hypothesize that the ambulatory approach is as good as the conventional approach in managing OSA in terms of improvement of clinical outcome but the former approach will lead to substantial cost savings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We conducted a prospective, randomized, controlled continuous positive airway pressure (CPAP) parallel study on new referrals to the Respiratory Clinic, Prince of Wales Hospital, with suspected obstructive sleep apnea (OSAS).
OSAS was defined by apnea-hypopnea index(AHI) 5/hr or more of sleep plus excessive daytime sleepiness or two of the following symptoms: choking or gasping during sleep, recurrent awakenings from sleep, unrefreshed sleep, daytime fatigue, and impaired concentration.
All patients with suspected OSAS underwent assessment at the clinic with the Epworth sleepiness score(ESS) and symptoms evaluation.
Patients who had ESS score>9 or at least two OSAS symptoms as described above were invited to join the study.
They were randomized into either group A)home-based management approach or group B)hospital-based management approach by a random table by a third party not involved in the trial.
Study Type
Interventional
Enrollment (Actual)
316
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong SAR, China
- The Chinese University of Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- symptoms of OSA with home sleep study AHI >= 15/hr.
Exclusion Criteria:
- unstable cardiovascular diseases (e.g. recent unstable angina, myocardial infarction, stroke or transient ischemic attack within the previous 6 months or severe left ventricular failure)
- neuromuscular disease affecting or potentially affecting respiratory muscles
- moderate to severe respiratory disease (i.e. breathlessness affecting activities of daily living) or documented hypoxemia or awake oxygen saturation of <92%
- psychiatric disease that limits the ability to give informed consent or complete the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Conventional polysomnography
Conventional PSG will be performed as in-patient at Prince of Wales Hospital for every subject in this group, recording electroencephalogram, electro-oculogram, submental electromyogram, bilateral anterior tibial electromyogram, electrocardiogram, chest & abdominal wall movement by inductance plethysmography, airflow measured by a nasal pressure transducer & supplemented by oronasal airflow thermistor, & finger pulse oximetry.
|
conventional type I sleep study according to international guidelines
|
|
ACTIVE_COMPARATOR: Home sleep study
The home sleep study is a pocket-sized digital recording device.
It is a multi-channel screening tool that measures airflow through a nasal cannula connected to a pressure transducer, providing an apnea-hypopnea index (AHI) based on recording time.
It also detects both respiratory and abdominal efforts through the effort sensor and can differentiate between obstructive and central events.
|
The home sleep study is a pocket-sized digital recording device.
It is a multi-channel screening tool that measures airflow through a nasal cannula connected to a pressure transducer, providing an apnea-hypopnea index (AHI) based on recording time.
It also detects both respiratory and abdominal efforts through the effort sensor and can differentiate between obstructive and central events
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Epworth Sleepiness Score (ESS) Before and After 3 Months of Continuous Positive Airway Pressure (CPAP) Treatment
Time Frame: Baseline and 3 months
|
The Epworth Sleepiness Scale (ESS) is a scale intended to measure daytime sleepiness that is measured by use of a very short questionnaire.
The questionnaire asks the subject to rate his or her probability of falling asleep on a scale of increasing probability from 0 to 3 for eight different situations that most people engage in during their daily lives, though not necessarily every day.
The scores for the eight questions are added together to obtain a single number.
A number in the 0-9 range is considered to be normal while a number in the 10-24 range indicates that expert medical advice should be sought.
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference in Healthcare Costs Between Ambulatory and Hospital Approach
Time Frame: within 24 months
|
within 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Hui, MD, Chinese University of Hong Kong
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
September 1, 2014
Study Registration Dates
First Submitted
April 8, 2013
First Submitted That Met QC Criteria
April 8, 2013
First Posted (ESTIMATE)
April 10, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 29, 2016
Last Update Submitted That Met QC Criteria
February 26, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- amb_hosp_OSA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OSA
-
Brigham and Women's HospitalRecruiting
-
Biocubica srlCompleted
-
Brigham and Women's HospitalRecruiting
-
Woolcock Institute of Medical ResearchFullpower Technologies, Inc.Recruiting
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Chang Gung Memorial HospitalUnknown
-
Changi General HospitalCompleted
-
Atlantic Health SystemNot yet recruitingPrevalence of OSA in Patients Hospitalized With COPD Exacerbation
Clinical Trials on conventional polysomnography
-
Assistance Publique - Hôpitaux de ParisCompletedObstructive Sleep Apnea | Spinal Cord InjuriesFrance
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of MelbourneMonash University; Western Sydney Local Health District; Royal Prince Alfred... and other collaboratorsRecruitingMotor Neuron Disease / Amyotrophic Lateral SclerosisAustralia
-
Hospital Universitario San Juan de AlicanteCompletedInfections | Community Acquired Pneumonia | Sleep Apnea Syndrome | PolygraphySpain
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Federal University of PelotasCompletedObstructive Sleep Apnea of ChildBrazil
-
Assiut UniversityCompleted
-
Poitiers University HospitalCompletedSleep Quality | Extubation FailureFrance
-
Poitiers University HospitalUnknownSleep Quality | Hypoxemic Acute Respiratory Failure | Intubation RiskFrance
-
Unity Health TorontoCompletedRespiratory InsufficiencyCanada